| Digital pathology based low-cost outcome predictor for ER+ Breast Cancers | Dr Vani Parmar, Professor & Surgeon, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Maharashtra | 2017 | Case Western Reserve University (CWRU), USA | Life Sciences & Biotechnology, Medical Sciences, Computer Sciences and Information Technology |
| Strengthening/promoting evidence-based advocacy for influenza prevention and control in India | Dr Anand Krishnan, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2017 | Centers for Disease Control and Prevention (CDC), Atlanta, USA | Life Sciences & Biotechnology, Medical Sciences |
| ENT COBRA: Standarized Data Collection (SDC) for head neck cancer patients treated with brachytherapy | Dr Ashwini Budrukkar, Professor & Radiation Oncologist, Tata Memorial Hospital (TMC), Maharashtra | 2017 | European Society for Radiotherapy & Oncology (GEC - ESTRO), Belgium | Life Sciences & Biotechnology, Medical Sciences |
| A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Crohns Disease | Dr Vineet Ahuja, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2017 | Gilead Sciences, Inc., USA | Life Sciences & Biotechnology, Medical Sciences |
| A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis | Dr Vineet Ahuja, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2017 | Gilead Sciences, Inc., USA | Life Sciences & Biotechnology, Medical Sciences |
| Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to sever active ulcerative colitis | Dr Vineet Ahuja, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2017 | Gilead Sciences, Inc., USA | Life Sciences & Biotechnology, Medical Sciences |
| Combined Phase 3, Double-blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to severely active crohn?s disease | Dr Vineet Ahuja, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2017 | Gilead Sciences, Inc., USA | Life Sciences & Biotechnology, Medical Sciences |
| A Randomized, Double-Blind Evaluation of the Pharmacokinetics, Safety, and Antiviral Efficacy of Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection | Dr Shalimar, Associate Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2017 | Gilead Sciences, Inc., USA | Life Sciences & Biotechnology, Medical Sciences |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Compensated Cirrhosis due to Nonalcoholic Steatohepatitis (NASH) | Dr Shalimar, Associate Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2017 | Gilead Sciences, Inc., USA | Life Sciences & Biotechnology, Medical Sciences |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis | Dr Shalimar, Associate Professor, All India Institute of Medical Sciences (AIIMS), New Delhi | 2017 | Gilead Sciences, Inc., USA | Life Sciences & Biotechnology, Medical Sciences |